{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-191944","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.849400+00:00","generated_at":"2026-05-15T02:18:55.046018+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Olema Pharmaceuticals appoints Dr. Prakash Raman to Board of Directors","bullets":["Dr. Raman appointed as Class II director effective April 28, 2026; term expires at 2028 annual meeting.","He brings over 20 years of biopharma experience; currently CEO of InduPro Therapeutics.","Received initial equity grants: option for 24,150 shares vesting monthly over 3 years, plus 2,911 shares vesting June 11, 2026.","Company highlights lead program palazestrant in two Phase 3 trials with OPERA-01 data expected fall 2026.","Board determined Dr. Raman is independent under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-191944","json":"https://secwatch.observer/filing/0001193125-26-191944.json","markdown":"https://secwatch.observer/filing/0001193125-26-191944.md","text":"https://secwatch.observer/filing/0001193125-26-191944.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526191944/0001193125-26-191944-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526191944/olma-20260427.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:18:55.046018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b34718143","claim":"Prakash Raman was appointed as Class II director at Olema Pharmaceuticals, Inc..","evidence_excerpt":"the Board appointed Dr. Prakash Raman to the Board as a Class II director, effective April 28, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526191944/0001193125-26-191944-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}